Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products. The Company serves medical markets and is engaged in therapeutic applications. The Company’s Phyto Extractions and Endgame Extracts brands distribute cannabis concentrate products through retailers at approximately 2,000 locations across Canada. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. It partners with healthcare professionals and practitioners within the regulated environment to create products suitable for the medical cannabis market. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., Chemia Analytics Inc., 1225140 B.C. Ltd and 1204581 B.C. Ltd.


CSE:XTRX - Post by User

Adastra Holdings Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1859)
•••
Post by lscfaon May 02, 2023 1:47am
236 Views
Post# 35424328

Fins on sedar

Fins on sedarProfitable cannabis co......

 

Qtr ending

Net Revenue

Gross profit

Margin

Op inc (loss)

Cfo

Q4 22

4,153,016

2,554,812

61.5%

885,855

925,497

Q3 22

3,803,787

1,635,457

43.0%

(423,557)

74,933

Q2 22

3,051,554

1,094,067

35.9%

(394,325)

163,008

Q1 22

2,286,721

827,713

36.2%

(867,969)

(544,713)

Q4 21

1,989,604

683,762

34.4%

(1,608,493)

(706,902)

Q3 21

1,808,111

818,878

45.3%

(109,097)

293,626

Q2 21

1,241,763

335,640

27.0%

(311,788)

270,392

Q1 21

589,138

105,411

17.9%

(362,360)

(141,849)

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities